FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Evangelia Kranias

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Disorders

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Chang Sik Park; Inju Park; Woo Jin Park; Vivek P Singh; Hong-Sheng Wang; Evangelia G Kranias; Hoyong Lee; Jae Gyun Oh; Donald M Bers; Hyeseon Cha; Shan Chen; Chunghee Cho; Clara Franzini-Armstrong; Kenneth S Ginsburg; Peidong Han; Sunghee Hong; Sora Jin; Do Han Kim
Targeted ablation of the histidine-rich Ca(2+)-binding protein (HRC) gene is associated with abnormal SR Ca(2+)-cycling and severe pathology under pressure-overload stress.
Kenneth M Fish; Lahouaria Hadri; Kiyotake Ishikawa; Dongtak Jeong; Ioannis Karakikes; Yoshiaki Kawase; Evangelia G Kranias; Dennis Ladage; Hung Ly; Jochen Muller-Ehmsen; R Jude Samulski; Lisa Tilemann; Roger J Hajjar
AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling.
Chi Keung Lam; Yong Liu; Xiaoping Ren; Nathan Robbins; Jack Rubinstein; Elizabeth Vafiadaki; Zhiguo Zhang; Wen Zhao; Xiaoyang Zhou; Wenfeng Cai; Stela M Florea; Min Jiang; W Keith Jones; Evangelia G Kranias
Novel role of HAX-1 in ischemic injury protection involvement of heat shock protein 90.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Evangelia Kranias (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Chang Sik Park; Inju Park; Woo Jin Park; Vivek P Singh; Hong-Sheng Wang; Evangelia G Kranias; Hoyong Lee; Jae Gyun Oh; Donald M Bers; Hyeseon Cha; Shan Chen; Chunghee Cho; Clara Franzini-Armstrong; Kenneth S Ginsburg; Peidong Han; Sunghee Hong; Sora Jin; Do Han Kim
Targeted ablation of the histidine-rich Ca(2+)-binding protein (HRC) gene is associated with abnormal SR Ca(2+)-cycling and severe pathology under pressure-overload stress.
Basic research in cardiology 2013;108(3):344.
2013: Kenneth M Fish; Lahouaria Hadri; Kiyotake Ishikawa; Dongtak Jeong; Ioannis Karakikes; Yoshiaki Kawase; Evangelia G Kranias; Dennis Ladage; Hung Ly; Jochen Muller-Ehmsen; R Jude Samulski; Lisa Tilemann; Roger J Hajjar
AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling.
Circulation. Heart failure 2013;6(2):310-7.
2013: Chi Keung Lam; Yong Liu; Xiaoping Ren; Nathan Robbins; Jack Rubinstein; Elizabeth Vafiadaki; Zhiguo Zhang; Wen Zhao; Xiaoyang Zhou; Wenfeng Cai; Stela M Florea; Min Jiang; W Keith Jones; Evangelia G Kranias
Novel role of HAX-1 in ischemic injury protection involvement of heat shock protein 90.
Circulation research 2013;112(1):79-89.
2012: Stela Florea; Kobra Haghighi; Ahmad Anjak; Wen-Feng Cai; Sarah Figueria; John Lorenz; Jiang Qian; Jack Rubinstein; Elizabeth Vafiadaki; Evangelia G Kranias
Constitutive phosphorylation of inhibitor-1 at Ser67 and Thr75 depresses calcium cycling in cardiomyocytes and leads to remodeling upon aging.
Basic research in cardiology 2012;107(5):279.
2012: Evangelia G Kranias; Roger J Hajjar
Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome.
Circulation research 2012;110(12):1646-60.
2012: Wen-Feng Cai; Stela Florea; Peidong Han; Chi-Kueng Lam; Stephan E Lehnart; Tracy Pritchard; Qunying Yuan; Xiaoyang Zhou; Paul D Allen; Evangelia G Kranias
Ablation of junctin or triadin is associated with increased cardiac injury following ischaemia/reperfusion.
Cardiovascular research 2012;94(2):333-41.
2012: Kobra Haghighi; Ahmad Anjak; Donald M Bers; Julie Bossuyt; Guo-Chang Fan; Hanna Osinska; Tracy Pritchard; Jeffrey Robbins; Jack Rubinstein; Jason R Waggoner; Qunying Yuan; Evangelia G Kranias
The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase.
Journal of molecular and cellular cardiology 2012;52(3):773-82.
2012: Yassine Sassi; Aniella Abi-Gerges; Stefan Engelhardt; Jeremy Fauconnier; Kobra Haghighi; Stephane N Hatem; Evangelia G Kranias; Alain Lacampagne; Anne-Marie Lompre; Andrew R Marks; Nathalie Mougenot; Steven Reiken; Jean-Sébastien Hulot
Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012;26(3):1009-17.
2012: Chang Sik Park; Woo Jin Park; Evangelia G Kranias; Eun Jeong Kwon; Hyeseon Cha; Chunghee Cho; Roger J Hajjar; Dongtak Jeong; Do Han Kim
AAV-mediated knock-down of HRC exacerbates transverse aorta constriction-induced heart failure.
PloS one 2012;7(8):e43282.
2012: Simona Boncompagni; Clara Franzini-Armstrong; Evangelia G Kranias; Jose R Lopez; Monique Thomas; Qunying Yuan; Paul D Allen; Claudio F Perez
Triadin/Junctin double null mouse reveals a differential role for Triadin and Junctin in anchoring CASQ to the jSR and regulating Ca(2+) homeostasis.
PloS one 2012;7(7):e39962.
2012: Xiaowei Zhang; Hongyan Zhu; Jiang Chang; Evangelia G Kranias; Tianqing Peng; Yaoliang Tang; Xiaohong Wang; Guo-Chang Fan
Hsp20 functions as a novel cardiokine in promoting angiogenesis via activation of VEGFR2.
PloS one 2012;7(3):e32765.
2011: Robert Gaffin; Paul H Goldspink; Lynley S Heinrich; Evangelia G Kranias; James R Peña; David F Wieczorek; Marco S L Alves; Shamim A K Chowdhury; Fernando A L Dias; Beata M Wolska
Long-term rescue of a familial hypertrophic cardiomyopathy caused by a mutation in the thin filament protein, tropomyosin, via modulation of a calcium cycling protein.
Journal of molecular and cellular cardiology 2011;51(5):812-20.
2011: Peidong Han; Demetrios A Arvanitis; Wenfeng Cai; Shan Chen; Heping Cheng; Chi Keung Lam; Vivek P Singh; Yanru Wang; Huiliang Zhang; Rongli Zhang; Evangelia G Kranias
Catecholaminergic-induced arrhythmias in failing cardiomyocytes associated with human HRCS96A variant overexpression.
American journal of physiology. Heart and circulatory physiology 2011;301(4):H1588-95.
2011: Guo-Chang Fan; Evangelia G Kranias
Small heat shock protein 20 (HspB6) in cardiac hypertrophy and failure.
Journal of molecular and cellular cardiology 2011;51(4):574-7.
2011: Jiang Qian; Patricia Rodriguez; Despina Sanoudou; Vivek P Singh; Weizhong Song; Elizabeth Vafiadaki; Hong-Sheng Wang; Yigang Wang; Qunying Yuan; Wenfeng Cai; Guo-Chang Fan; Stela M Florea; Kobra Haghighi; Chi Kung Lam; Tracy J Pritchard; Evangelia G Kranias
Small heat shock protein 20 interacts with protein phosphatase-1 and enhances sarcoplasmic reticulum calcium cycling.
Circulation research 2011;108(12):1429-38.
2011: Alicia Mattiazzi; Evangelia G Kranias
CaMKII regulation of phospholamban and SR Ca2+ load.
Heart rhythm : the official journal of the Heart Rhythm Society 2011;8(5):784-7.
2011: Hong-Sheng Wang; Demetrios A Arvanitis; Min Dong; Paul J Niklewski; Wen Zhao; Chi Keung Lam; Evangelia G Kranias; Despina Sanoudou
SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts.
Physiological genomics 2011;43(7):357-64.
2011: Sanjeewa A Goonasekera; Chi K Lam; Douglas P Millay; Michelle A Sargent; Roger J Hajjar; Evangelia G Kranias; Jeffery D Molkentin
Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle.
The Journal of clinical investigation 2011;121(3):1044-52.
2011: Demetrios A Arvanitis; Elizabeth Vafiadaki; Despina Sanoudou; Evangelia G Kranias
Histidine-rich calcium binding protein: the new regulator of sarcoplasmic reticulum calcium cycling.
Journal of molecular and cellular cardiology 2011;50(1):43-9.
2010: Guoli Chen; Xiaoyang Zhou; Stela Florea; Jiang Qian; Wenfeng Cai; Zhiguo Zhang; Guo-Chang Fan; John Lorenz; Roger J Hajjar; Evangelia G Kranias
Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis.
Basic research in cardiology 2010;105(5):573-81.
2010: Lahouaria Hadri; Regis Bobe; Yoshiaki Kawase; Dennis Ladage; Kiyotake Ishikawa; Fabrice Atassi; Djamel Lebeche; Evangelia G Kranias; Jane A Leopold; Anne-Marie Lompré; Larissa Lipskaia; Roger J Hajjar
SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells.
Molecular therapy : the journal of the American Society of Gene Therapy 2010;18(7):1284-92.
2010: Margarita A Salas; Carlos A Valverde; Gina Sánchez; Matilde Said; Jesica S Rodriguez; Enrique Portiansky; Marcia A Kaetzel; John R Dedman; Paulina Donoso; Evangelia G Kranias; Alicia Mattiazzi
The signalling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia/reperfusion injury.
Journal of molecular and cellular cardiology 2010;48(6):1298-306.
2010: Anne-Marie Lompré; Roger J Hajjar; Sian E Harding; Evangelia G Kranias; Martin J Lohse; Andrew R Marks
Ca2+ cycling and new therapeutic approaches for heart failure.
Circulation 2010;121(6):822-30.
2010: Tong Zhang; Tao Guo; Shikha Mishra; Nancy Dalton; Evangelia G Kranias; Kirk L Peterson; Donald M Bers; Joan Heller Brown
Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice.
Circulation research 2010;106(2):354-62.
2010: Elizabeth Vafiadaki; Demetrios A Arvanitis; Evangelia G Kranias; Despina Sanoudou
Pharmacogenetically tailored treatments for heart disease.
Current pharmaceutical design 2010;16(20):2194-213.
2009: Wen Zhao; Jason R Waggoner; Zhi-Guo Zhang; Chi Keung Lam; Peidong Han; Jiang Qian; Paul M Schroder; Bryan Mitton; Aikaterini Kontrogianni-Konstantopoulos; Seth L Robia; Evangelia G Kranias
The anti-apoptotic protein HAX-1 is a regulator of cardiac function.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(49):20776-81.
2009: Jiang Qian; Xiaoping Ren; Xiaohong Wang; Pengyuan Zhang; W Keith Jones; Jeffery D Molkentin; Guo-Chang Fan; Evangelia G Kranias
Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death.
Circulation research 2009;105(12):1223-31.
2009: Xiaohong Wang; Tiemin Zhao; Wei Huang; Tao Wang; Jiang Qian; Meifeng Xu; Evangelia G Kranias; Yigang Wang; Guo-Chang Fan
Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors.
Stem cells (Dayton, Ohio) 2009;27(12):3021-31.
2009: Vasiliki Papalouka; Demetrios A Arvanitis; Elizabeth Vafiadaki; Manolis Mavroidis; Stavroula A Papadodima; Chara A Spiliopoulou; Dimitrios T Kremastinos; Evangelia G Kranias; Despina Sanoudou
Muscle LIM protein interacts with cofilin 2 and regulates F-actin dynamics in cardiac and skeletal muscle.
Molecular and cellular biology 2009;29(22):6046-58.
2009: W Keith Jones; Guo-Chang Fan; Siyun Liao; Jun-Ming Zhang; Yang Wang; Neal L Weintraub; Evangelia G Kranias; Jo El Schultz; John Lorenz; Xiaoping Ren
Peripheral nociception associated with surgical incision elicits remote nonischemic cardioprotection via neurogenic activation of protein kinase C signaling.
Circulation 2009;120(11 Suppl):S1-9.
2009: Xiaohong Wang; Basilia Zingarelli; Michael O'Connor; Pengyuan Zhang; Adeola Adeyemo; Evangelia G Kranias; Yigang Wang; Guo-Chang Fan
Overexpression of Hsp20 prevents endotoxin-induced myocardial dysfunction and apoptosis via inhibition of NF-kappaB activation.
Journal of molecular and cellular cardiology 2009;47(3):382-90.
2009: Persoulla Nicolaou; Roger J Hajjar; Evangelia G Kranias
Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology.
Journal of molecular and cellular cardiology 2009;47(3):365-71.
2009: Qinghang Liu; Xiongwen Chen; Scott M Macdonnell; Evangelia G Kranias; John N Lorenz; Michael Leitges; Steven R Houser; Jeffery D Molkentin
Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.
Circulation research 2009;105(2):194-200.
2009: Tracy J Pritchard; Evangelia G Kranias
Junctin and the histidine-rich Ca2+ binding protein: potential roles in heart failure and arrhythmogenesis.
The Journal of physiology 2009;587(Pt 13):3125-33.
2009: Wen Zhao; Guo-Chang Fan; Zhi-Guo Zhang; Arun Bandyopadhyay; Xiaoyang Zhou; Evangelia G Kranias
Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis.
Basic research in cardiology 2009;104(4):377-89.
2009: Qunying Yuan; Peidong Han; Min Dong; Xiaoping Ren; Xiaoyang Zhou; Shan Chen; W Keith Jones; Guoxiang Chu; Hong-Sheng Wang; Evangelia G Kranias
Partial downregulation of junctin enhances cardiac calcium cycling without eliciting ventricular arrhythmias in mice.
American journal of physiology. Heart and circulatory physiology 2009;296(5):H1484-90.
2009: Persoulla Nicolaou; Patricia Rodriguez; Xiaoping Ren; Xiaoyang Zhou; Jiang Qian; Sakthivel Sadayappan; Bryan Mitton; Anand Pathak; Jeffrey Robbins; Roger J Hajjar; Keith Jones; Evangelia G Kranias
Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury.
Circulation research 2009;104(8):1012-20.
2009: Jason R Waggoner; Kenneth S Ginsburg; Bryan Mitton; Kobra Haghighi; Jeffrey Robbins; Donald M Bers; Evangelia G Kranias
Phospholamban overexpression in rabbit ventricular myocytes does not alter sarcoplasmic reticulum Ca transport.
American journal of physiology. Heart and circulatory physiology 2009;296(3):H698-703.
2009: Persoulla Nicolaou; Evangelia G Kranias
Role of PP1 in the regulation of Ca cycling in cardiac physiology and pathophysiology.
Frontiers in bioscience : a journal and virtual library 2009;14():3571-85.
2009: Abhinav Diwan; Scot J Matkovich; Qunying Yuan; Wen Zhao; Atsuko Yatani; Joan Heller Brown; Jeffery D Molkentin; Evangelia G Kranias; Gerald W Dorn
Endoplasmic reticulum-mitochondria crosstalk in NIX-mediated murine cell death.
The Journal of clinical investigation 2009;119(1):203-12.
2009: Elizabeth Vafiadaki; Demetrios A Arvanitis; Stamatis N Pagakis; Vasiliki Papalouka; Despina Sanoudou; Aikaterini Kontrogianni-Konstantopoulos; Evangelia G Kranias
The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival.
Molecular biology of the cell 2009;20(1):306-18.
2009: Guoli Chen; Xiaoyang Zhou; Anand Pathak; Gerald W Dorn; Evangelia G Kranias
The human G147D-protein phosphatase 1 inhibitor-1 polymorphism is not associated with altered clinical characteristics in heart failure.
Cardiology 2009;112(3):224-31.
2009: Elizabeth Vafiadaki; Vasiliki Papalouka; Demetrios A Arvanitis; Evangelia G Kranias; Despina Sanoudou
The role of SERCA2a/PLN complex, Ca(2+) homeostasis, and anti-apoptotic proteins in determining cell fate.
Pflügers Archiv : European journal of physiology 2009;457(3):687-700.
2008: Guo-Chang Fan; Xiaoyang Zhou; Xiaohong Wang; Guojie Song; Jiang Qian; Persoulla Nicolaou; Guoli Chen; Xiaoping Ren; Evangelia G Kranias
Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.
Circulation research 2008;103(11):1270-9.
2008: Demetrios A Arvanitis; Despina Sanoudou; Fotis Kolokathis; Elizabeth Vafiadaki; Vasiliki Papalouka; Aikaterini Kontrogianni-Konstantopoulos; George N Theodorakis; Ioannis A Paraskevaidis; Stamatios Adamopoulos; Gerald W Dorn; Dimitrios Th Kremastinos; Evangelia G Kranias
The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy.
European heart journal 2008;29(20):2514-25.
2008: Guoli Chen; Xiaoyang Zhou; Persoulla Nicolaou; Patricia Rodriguez; Guojie Song; Bryan Mitton; Anand Pathak; Amit Zachariah; Guo-Chang Fan; Gerald W Dorn; Evangelia G Kranias
A human polymorphism of protein phosphatase-1 inhibitor-1 is associated with attenuated contractile response of cardiomyocytes to beta-adrenergic stimulation.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(6):1790-6.
2008: Kobra Haghighi; Guoli Chen; Yoji Sato; Guo-Chang Fan; Suiwen He; Fotis Kolokathis; Luke Pater; Ioannis Paraskevaidis; W Keith Jones; Gerald W Dorn; Dimitrios Th Kremastinos; Evangelia G Kranias
A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids.
Human mutation 2008;29(5):640-7.
2008: James Scott Pattison; Jason R Waggoner; Jeanne James; Lisa Martin; James Gulick; Hanna Osinska; Raisa Klevitsky; Evangelia G Kranias; Jeffrey Robbins
Phospholamban overexpression in transgenic rabbits.
Transgenic research 2008;17(2):157-70.
2008: Yin Hua Zhang; Mei Hua Zhang; Claire E Sears; Krzysztof Emanuel; Charles Redwood; Ali El-Armouche; Evangelia G Kranias; Barbara Casadei
Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice.
Circulation research 2008;102(2):242-9.
2008: Guo-Chang Fan; Qunying Yuan; Evangelia G Kranias
Regulatory roles of junctin in sarcoplasmic reticulum calcium cycling and myocardial function.
Trends in cardiovascular medicine 2008;18(1):1-5.
2007: Demetrios A Arvanitis; Elizabeth Vafiadaki; Guo-Chang Fan; Bryan Mitton; Kimberly N Gregory; Federica del Monte; Aikaterini Kontrogianni-Konstantopoulos; Despina Sanoudou; Evangelia G Kranias
Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase.
American journal of physiology. Heart and circulatory physiology 2007;293(3):H1581-9.
2007: Xiaoyang Zhou; Guo-Chang Fan; Xiaoping Ren; Jason R Waggoner; Kimberly N Gregory; Guoli Chen; W Keith Jones; Evangelia G Kranias
Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury.
Cardiovascular research 2007;75(3):487-97.
2007: Patricia Rodriguez; Bryan Mitton; Persoulla Nicolaou; Guoli Chen; Evangelia G Kranias
Phosphorylation of human inhibitor-1 at Ser67 and/or Thr75 attenuates stimulatory effects of protein kinase A signaling in cardiac myocytes.
American journal of physiology. Heart and circulatory physiology 2007;293(1):H762-9.
2007: Elizabeth Vafiadaki; Despina Sanoudou; Demetrios A Arvanitis; Dawn H Catino; Evangelia G Kranias; Aikaterini Kontrogianni-Konstantopoulos
Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function.
Journal of molecular biology 2007;367(1):65-79.
2007: Martín G Vila Petroff; Margarita A Salas; Matilde Said; Carlos A Valverde; Luciana Sapia; Enrique Portiansky; Roger J Hajjar; Evangelia G Kranias; Cecilia Mundiña-Weilenmann; Alicia Mattiazzi
CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury.
Cardiovascular research 2007;73(4):689-98.
2007: Qunying Yuan; Guo-Chang Fan; Min Dong; Beth Altschafl; Abhinav Diwan; Xiaoping Ren; Harvey H Hahn; Wen Zhao; Jason R Waggoner; Larry R Jones; W Keith Jones; Donald M Bers; Gerald W Dorn; Hong-Sheng Wang; Héctor H Valdivia; Guoxiang Chu; Evangelia G Kranias
Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity.
Circulation 2007;115(3):300-9.
2007: Guo-Chang Fan; Qunying Yuan; Wen Zhao; Guoxiang Chu; Evangelia G Kranias
Junctin is a prominent regulator of contractility in cardiomyocytes.
Biochemical and biophysical research communications 2007;352(3):617-22.
2007: Evangelia G Kranias; Donald M Bers
Calcium and cardiomyopathies.
Sub-cellular biochemistry 2007;45():523-37.
2007: Anand Pathak; Brent Baldwin; Evangelia G Kranias
Key protein alterations associated with hyperdynamic cardiac function: insights based on proteomic analysis of the protein phosphatase 1 inhibitor-1 overexpressing hearts.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2007;48(1):30-6.
2006: Patricia Rodriguez; Bryan Mitton; Jason R Waggoner; Evangelia G Kranias
Identification of a novel phosphorylation site in protein phosphatase inhibitor-1 as a negative regulator of cardiac function.
The Journal of biological chemistry 2006;281(50):38599-608.
2006: Guo-Chang Fan; Qunying Yuan; Guojie Song; Yigang Wang; Guoli Chen; Jiang Qian; Xiaoyang Zhou; Yong J Lee; Muhammad Ashraf; Evangelia G Kranias
Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1.
Circulation research 2006;99(11):1233-42.
2006: Dennis W McGraw; Kevin M Fogel; Sue Kong; Augusto A Litonjua; Evangelia G Kranias; Bruce Aronow; Stephen B Liggett
Transcriptional response to persistent beta2-adrenergic receptor signaling reveals regulation of phospholamban, which alters airway contractility.
Physiological genomics 2006;27(2):171-7.
2006: Peter Vangheluwe; Marc Tjwa; An Van den Bergh; William E Louch; Monique Beullens; Leonard Dode; Peter Carmeliet; Evangelia G Kranias; Paul Herijgers; Karin R Sipido; Luc Raeymaekers; Frank Wuytack
A SERCA2 pump with an increased Ca2+ affinity can lead to severe cardiac hypertrophy, stress intolerance and reduced life span.
Journal of molecular and cellular cardiology 2006;41(2):308-17.
2006: Kimberly N Gregory; Evangelia G Kranias
Targeting sarcoplasmic reticulum calcium handling proteins as therapy for cardiac disease.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2006;47(3):132-43.
2006: Alicia Mattiazzi; Cecilia Mundiña-Weilenmann; Leticia Vittone; Matilde Said; Evangelia G Kranias
The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2006;39(5):563-72.
2006: Kimberly N Gregory; Kenneth S Ginsburg; Ilona Bodi; Harvey Hahn; Yehia Marreez; Qiujing Song; Prabhu A Padmanabhan; Bryan Mitton; Jason R Waggoner; Federica del Monte; Woo Jin Park; Gerald W Dorn; Donald M Bers; Evangelia G Kranias
Histidine-rich Ca binding protein: a regulator of sarcoplasmic reticulum calcium sequestration and cardiac function.
Journal of molecular and cellular cardiology 2006;40(5):653-65.
2006: Carlos A Valverde; Cecilia Mundiña-Weilenmann; Mariano Reyes; Evangelia G Kranias; Ariel L Escobar; Alicia Mattiazzi
Phospholamban phosphorylation sites enhance the recovery of intracellular Ca2+ after perfusion arrest in isolated, perfused mouse heart.
Cardiovascular research 2006;70(2):335-45.
2006: Wen Zhao; Qunying Yuan; Jiang Qian; Jason R Waggoner; Anand Pathak; Guoxiang Chu; Bryan Mitton; Xiaoyin Sun; Jay Jin; Julian C Braz; Harvey S Hahn; Yehia Marreez; Faisal M Syed; Piero Pollesello; Arto Annila; Hong-Sheng Wang; Jo El J Schultz; Jeffery D Molkentin; Stephen B Liggett; Gerald W Dorn; Evangelia G Kranias
The presence of Lys27 instead of Asn27 in human phospholamban promotes sarcoplasmic reticulum Ca2+-ATPase superinhibition and cardiac remodeling.
Circulation 2006;113(7):995-1004.
2006: Anthony O Gramolini; Maria G Trivieri; Gavin Y Oudit; Thomas Kislinger; Wenping Li; Mikin M Patel; Andrew Emili; Evangelia G Kranias; Peter H Backx; David H MacLennan
Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(7):2446-51.
2006: Yuejin Wu; Ayumi Shintani; Chad E Grueter; Rong Zhang; Yue Hou; Jinying Yang; Evangelia G Kranias; Roger J Colbran; Mark E Anderson
Suppression of dynamic Ca(2+) transient responses to pacing in ventricular myocytes from mice with genetic calmodulin kinase II inhibition.
Journal of molecular and cellular cardiology 2006;40(2):213-23.
2006: Yong Ji; Wen Zhao; Bailing Li; Jaime DeSantiago; Eckard Picht; Marcia A Kaetzel; Jo El J Schultz; Evangelia G Kranias; Donald M Bers; John R Dedman
Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility.
American journal of physiology. Heart and circulatory physiology 2006;290(2):H599-606.
2006: Kobra Haghighi; Fotis Kolokathis; Anthony O Gramolini; Jason R Waggoner; Luke Pater; Roy A Lynch; Guo-Chang Fan; Dimitris Tsiapras; Rohan R Parekh; Gerald W Dorn; David H MacLennan; Dimitrios Th Kremastinos; Evangelia G Kranias
A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(5):1388-93.
2006: Guoxiang Chu; Evangelia G Kranias
Phospholamban as a therapeutic modality in heart failure.
Novartis Foundation symposium 2006;274():156-71; discussion 172-5, 272-6.
2005: P Rodriguez; Evangelia G Kranias
Phospholamban: a key determinant of cardiac function and dysfunction.
Archives des maladies du coeur et des vaisseaux 2005;98(12):1239-43.
2005: Patricia Rodriguez; Bryan Mitton; Evangelia G Kranias
Phosphorylation of glutathione-S-transferase by protein kinase C-alpha implications for affinity-tag purification.
Biotechnology letters 2005;27(23-24):1869-73.
2005: Alicia Mattiazzi; Cecilia Mundiña-Weilenmann; Chu Guoxiang; Leticia Vittone; Evangelia G Kranias
Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions.
Cardiovascular research 2005;68(3):366-75.
2005: Jason R Waggoner; Evangelia G Kranias
Role of phospholamban in the pathogenesis of heart failure.
Heart failure clinics 2005;1(2):207-18.
2005: Guo-Chang Fan; Guoxiang Chu; Evangelia G Kranias
Hsp20 and its cardioprotection.
Trends in cardiovascular medicine 2005;15(4):138-41.
2005: Anand Pathak; Federica del Monte; Wen Zhao; Jo-El Schultz; John N Lorenz; Ilona Bodi; Doug Weiser; Harvey Hahn; Andrew N Carr; Faisal M Syed; Nirmala Mavila; Leena Jha; Jiang Qian; Yehia Marreez; Guoli Chen; Dennis W McGraw; E Kevin Heist; J Luis Guerrero; Anna A DePaoli-Roach; Roger J Hajjar; Evangelia G Kranias
Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1.
Circulation research 2005;96(7):756-66.
2005: Despina Sanoudou; Elizabeth Vafiadaki; Demetrios A Arvanitis; Evangelia G Kranias; Aikaterini Kontrogianni-Konstantopoulos
Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies.
Physiological genomics 2005;21(2):131-43.
2005: Guo-Chang Fan; Xiaoping Ren; Jiang Qian; Qunying Yuan; Persoulla Nicolaou; Yang Wang; W Keith Jones; Guoxiang Chu; Evangelia G Kranias
Novel cardioprotective role of a small heat-shock protein, Hsp20, against ischemia/reperfusion injury.
Circulation 2005;111(14):1792-9.
2005: Cecilia Mundiña-Weilenmann; Paola Ferrero; Matilde Said; Leticia Vittone; Evangelia G Kranias; Alicia Mattiazzi
Role of phosphorylation of Thr(17) residue of phospholamban in mechanical recovery during hypercapnic acidosis.
Cardiovascular research 2005;66(1):114-22.
2004: Guoxiang Chu; Jaclyn P Kerr; Bryan Mitton; Gregory F Egnaczyk; Jenny A Vazquez; Meilan Shen; Greg W Kilby; Tracy I Stevenson; John E Maggio; Jerry Vockley; Stephen T Rapundalo; Evangelia G Kranias
Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(14):1725-7.
2004: Péter Szentesi; Christophe Pignier; Marcel Egger; Evangelia G Kranias; Ernst Niggli
Sarcoplasmic reticulum Ca2+ refilling controls recovery from Ca2+-induced Ca2+ release refractoriness in heart muscle.
Circulation research 2004;95(8):807-13.
2004: Kobra Haghighi; Kimberly N Gregory; Evangelia G Kranias
Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.
Biochemical and biophysical research communications 2004;322(4):1214-22.
2004: Guo-Chang Fan; Kimberly N Gregory; Wen Zhao; Woo Jin Park; Evangelia G Kranias
Regulation of myocardial function by histidine-rich, calcium-binding protein.
American journal of physiology. Heart and circulatory physiology 2004;287(4):H1705-11.
2004: Wen Zhao; Yoshiki Uehara; Guoxiang Chu; Qiujing Song; Jiang Qian; Karen Young; Evangelia G Kranias
Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractility.
Journal of molecular and cellular cardiology 2004;37(2):607-12.
2004: Roy L Sutliff; Laura Conforti; Craig S Weber; Evangelia G Kranias; Richard J Paul
Regulation of the spontaneous contractile activity of the portal vein by the sarcoplasmic reticulum: evidence from the phospholamban gene-ablated mouse.
Vascular pharmacology 2004;41(6):197-204.
2004: Guo-Chang Fan; Guoxiang Chu; Bryan Mitton; Qiujing Song; Qunying Yuan; Evangelia G Kranias
Small heat-shock protein Hsp20 phosphorylation inhibits beta-agonist-induced cardiac apoptosis.
Circulation research 2004;94(11):1474-82.
2004: Andrzej M Janczewski; Maliha Zahid; Bonnie Lemster; Carole S Frye; Gregory Gibson; Yoshihiro Higuchi; Evangelia G Kranias; Arthur M Feldman; Charles F McTiernan
Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model.
Cardiovascular research 2004;62(3):468-80.
2004: Qiujing Song; Karen B Young; Guoxiang Chu; James Gulick; Michael J Gerst; Ingrid L Grupp; Jeffrey Robbins; Evangelia G Kranias
Overexpression of phospholamban in slow-twitch skeletal muscle is associated with depressed contractile function and muscle remodeling.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(9):974-6.
2004: Atsuko Yatani; Song-Jung Kim; Raymond K Kudej; Qian Wang; Christophe Depre; Keiichi Irie; Evangelia G Kranias; Stephen F Vatner; Dorothy E Vatner
Insights into cardioprotection obtained from study of cellular Ca2+ handling in myocardium of true hibernating mammals.
American journal of physiology. Heart and circulatory physiology 2004;286(6):H2219-28.
2004: Stefan Engelhardt; Lutz Hein; Vitaly Dyachenkow; Evangelia G Kranias; Gerrit Isenberg; Martin J Lohse
Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation.
Circulation 2004;109(9):1154-60.
2004: Julian C Braz; Kimberly Gregory; Anand Pathak; Wen Zhao; Bogachan Sahin; Raisa Klevitsky; Thomas F Kimball; John N Lorenz; Angus Nairn; Stephen B Liggett; Ilona Bodi; Su Wang; Arnold Schwartz; Edward G Lakatta; Anna A DePaoli-Roach; Jeffrey Robbins; Timothy E Hewett; James A Bibb; Margaret V Westfall; Evangelia G Kranias; Jeffery D Molkentin
PKC-alpha regulates cardiac contractility and propensity toward heart failure.
Nature medicine 2004;10(3):248-54.
2004: Yan Pan; Thomas Kislinger; Anthony O Gramolini; Elena Zvaritch; Evangelia G Kranias; David H MacLennan; Andrew Emili
Identification of biochemical adaptations in hyper- or hypocontractile hearts from phospholamban mutant mice by expression proteomics.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(8):2241-6.
2004: Guoxiang Chu; Gregory F Egnaczyk; Wen Zhao; Su-Hyun Jo; Guo-Chang Fan; John E Maggio; Rui-Ping Xiao; Evangelia G Kranias
Phosphoproteome analysis of cardiomyocytes subjected to beta-adrenergic stimulation: identification and characterization of a cardiac heat shock protein p20.
Circulation research 2004;94(2):184-93.
2004: Kimberly N Gregory; Harvey Hahn; Kobra Haghighi; Yehia Marreez; Amy Odley; Gerald W Dorn; Evangelia G Kranias
Increased particulate partitioning of PKC epsilon reverses susceptibility of phospholamban knockout hearts to ischemic injury.
Journal of molecular and cellular cardiology 2004;36(2):313-8.
2003: Matilde Said; Leticia Vittone; C Mundina-Weilenmann; Paola Ferrero; Evangelia G Kranias; Alicia Mattiazzi
Role of dual-site phospholamban phosphorylation in the stunned heart: insights from phospholamban site-specific mutants.
American journal of physiology. Heart and circulatory physiology 2003;285(3):H1198-205.
2003: David H MacLennan; Evangelia G Kranias
Phospholamban: a crucial regulator of cardiac contractility.
Nature reviews. Molecular cell biology 2003;4(7):566-77.
2003: Albrecht G Schmidt; Kobra Haghighi; Beate Frank; Luke Pater; Gerald W Dorn; Richard A Walsh; Evangelia G Kranias
Polymorphic SERCA2a variants do not account for inter-individual differences in phospholamban-SERCA2a interactions in human heart failure.
Journal of molecular and cellular cardiology 2003;35(7):867-70.
2003: Angela G Brittsan; Kenneth S Ginsburg; Guoxiang Chu; Atsuko Yatani; Beata M Wolska; Albrecht G Schmidt; Michio Asahi; David H MacLennan; Donald M Bers; Evangelia G Kranias
Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport.
Circulation research 2003;92(7):769-76.
2003: Kobra Haghighi; Fotis Kolokathis; Luke Pater; Roy A Lynch; Michio Asahi; Anthony O Gramolini; Guo-Chang Fan; Dimitris Tsiapras; Harvey S Hahn; Stamatis Adamopoulos; Stephen B Liggett; Gerald W Dorn; David H MacLennan; Dimitrios Th Kremastinos; Evangelia G Kranias
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human.
The Journal of clinical investigation 2003;111(6):869-76.
2003: Qiujing Song; Albrecht G Schmidt; Harvey S Hahn; Andrew N Carr; Beate Frank; Luke Pater; Michael J Gerst; Karen Young; Brian D Hoit; Bradley K McConnell; Kobra Haghighi; Christine E Seidman; Jonathan G Seidman; Gerald W Dorn; Evangelia G Kranias
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy.
The Journal of clinical investigation 2003;111(6):859-67.
2003: Rajesh Dash; Albrecht G Schmidt; Anand Pathak; Michael J Gerst; Danuta Biniakiewicz; Vivek J Kadambi; Brian D Hoit; William T Abraham; Evangelia G Kranias
Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy.
Cardiovascular research 2003;57(3):704-14.
2003: Joachim P Schmitt; Mitsuhiro Kamisago; Michio Asahi; Guo Hua Li; Ferhaan Ahmad; Ulrike Mende; Evangelia G Kranias; David H MacLennan; Jonathan G Seidman; Christine E Seidman
Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.
Science (New York, N.Y.) 2003;299(5611):1410-3.
2003: Takayoshi Isoda; Nazareno Paolocci; Kobra Haghighi; Congrong Wang; Yibin Wang; Dimitrios Georgakopoulos; Giuseppe Servillo; Maria Agnese Della Fazia; Evangelia G Kranias; Anna A DePaoli-Roach; Paolo Sassone-Corsi; David A Kass
Novel regulation of cardiac force-frequency relation by CREM (cAMP response element modulator).
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(2):144-51.
2003: Heather R Cross; Evangelia G Kranias; Elizabeth Murphy; CHARLES STEENBERGEN
Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO.
American journal of physiology. Heart and circulatory physiology 2003;284(2):H683-90.
2003: Yoji Sato; Albrecht G Schmidt; Helen Kiriazis; Brian D Hoit; Evangelia G Kranias
Compensated hypertrophy of cardiac ventricles in aged transgenic FVB/N mice overexpressing calsequestrin.
Molecular and cellular biochemistry 2003;242(1-2):19-25.
2003: Wen Zhao; Konrad Frank; Guoxiang Chu; Michael J Gerst; Albrecht G Schmidt; Yong Ji; Muthu Periasamy; Evangelia G Kranias
Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state.
Cardiovascular research 2003;57(1):71-81.
2002: Guoxiang Chu; Kobra Haghighi; Evangelia G Kranias
From mouse to man: understanding heart failure through genetically altered mouse models.
Journal of cardiac failure 2002;8(6 Suppl):S432-49.
2002: Albrecht G Schmidt; Jing Zhai; Andrew N Carr; Michael J Gerst; John N Lorenz; Piero Pollesello; Arto Annila; Brian D Hoit; Evangelia G Kranias
Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure.
Cardiovascular research 2002;56(2):248-59.
2002: Albrecht G Schmidt; Michael J Gerst; Jing Zhai; Andrew N Carr; Luke Pater; Evangelia G Kranias; Brian D Hoit
Evaluation of left ventricular diastolic function from spectral and color M-mode Doppler in genetically altered mice.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2002;15(10 Pt 1):1065-73.
2002: Evangelia G Kranias
Introduction.
Journal of molecular and cellular cardiology 2002;34(8):883.
2002: Andrew N Carr; Evangelia G Kranias
Thyroid hormone regulation of calcium cycling proteins.
Thyroid : official journal of the American Thyroid Association 2002;12(6):453-7.
2002: Andrew N Carr; Albrecht G Schmidt; Yoichi Suzuki; Federica del Monte; Yoji Sato; Carita Lanner; Kristine Breeden; Shao-Ling Jing; Patrick B Allen; Paul Greengard; Atsuko Yatani; Brian D Hoit; Ingrid L Grupp; Roger J Hajjar; Anna A DePaoli-Roach; Evangelia G Kranias
Type 1 phosphatase, a negative regulator of cardiac function.
Molecular and cellular biology 2002;22(12):4124-35.
2002: Beata M Wolska; Grace M Arteaga; James R Peña; Grzegorz Nowak; Ronald M Phillips; Shalini Sahai; Pieter P de Tombe; Anne F Martin; Evangelia G Kranias; R John Solaro
Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of beta-adrenergic stimulation.
Circulation research 2002;90(8):882-8.
2002: YeQing Pi; Kara R Kemnitz; Dahua Zhang; Evangelia G Kranias; Jeffery W Walker
Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice.
Circulation research 2002;90(6):649-56.
2002: Guoxiang Chu; Andrew N Carr; Karen B Young; J William Lester; Atsuko Yatani; Atsushi Sanbe; Melissa C Colbert; Steven M Schwartz; Konrad Frank; Paul D Lampe; Jeffrey Robbins; Jeffery D Molkentin; Evangelia G Kranias
Enhanced myocyte contractility and Ca2+ handling in a calcineurin transgenic model of heart failure.
Cardiovascular research 2002;54(1):105-16.
2002: Yanxia Li; Evangelia G Kranias; Gregory A Mignery; Donald M Bers
Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes.
Circulation research 2002;90(3):309-16.
2002: Helen Kiriazis; Yoji Sato; Vivek J Kadambi; Albrecht G Schmidt; Michael J Gerst; Brian D Hoit; Evangelia G Kranias
Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis.
Cardiovascular research 2002;53(2):372-81.
2002: Klara Brixius; Persephone Savvidou-Zaroti; Uwe Mehlhorn; Wilhelm Bloch; Evangelia G Kranias; Robert H G Schwinger
Increased Ca2+-sensitivity of myofibrillar tension in heart failure and its functional implication.
Basic research in cardiology 2002;97 Suppl 1():I111-7.
2002: Konrad Frank; Birgit Bölck; Klara Brixius; Evangelia G Kranias; Robert H G Schwinger
Modulation of SERCA: implications for the failing human heart.
Basic research in cardiology 2002;97 Suppl 1():I72-8.
2002: Guoxiang Chu; Evangelia G Kranias
Functional interplay between dual site phospholambam phosphorylation: insights from genetically altered mouse models.
Basic research in cardiology 2002;97 Suppl 1():I43-8.
2002: Richard J Paul; Gary E Shull; Evangelia G Kranias
The sarcoplasmic reticulum and smooth muscle function: evidence from transgenic mice.
Novartis Foundation symposium 2002;246():228-38; discussion 238-43, 272-6.
2001: Konrad Frank; L Mesnard-Rouiller; Guoxiang Chu; Karen B Young; Wen Zhao; Kobra Haghighi; Yoji Sato; Evangelia G Kranias
Structure and expression of the mouse cardiac calsequestrin gene.
Basic research in cardiology 2001;96(6):636-44.
2001: Koji Nobe; Roy L Sutliff; Evangelia G Kranias; Richard J Paul
Phospholamban regulation of bladder contractility: evidence from gene-altered mouse models.
The Journal of physiology 2001;535(Pt 3):867-78.
2001: Albrecht G Schmidt; István Ferenc Édes; Evangelia G Kranias
Phospholamban: a promising therapeutic target in heart failure?
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2001;15(5):387-96.
2001: Y Sato; Albrecht G Schmidt; Helen Kiriazis; Brian D Hoit; Evangelia G Kranias
Letter to the editor: Re-evaluation of heart failure in transgenic mice with impaired SR Ca2+ release.
Journal of molecular and cellular cardiology 2001;33(9):1757-9.
2001: Andrew N Carr; Roy L Sutliff; Craig S Weber; P B Allen; Paul Greengard; Primal De Lanerolle; Evangelia G Kranias; Richard J Paul
Is myosin phosphatase regulated in vivo by inhibitor-1? Evidence from inhibitor-1 knockout mice.
The Journal of physiology 2001;534(Pt. 2):357-66.
2001: Rajesh Dash; Konrad Frank; Andrew N Carr; Christine S Moravec; Evangelia G Kranias
Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.
Journal of molecular and cellular cardiology 2001;33(7):1345-53.
2001: Kobra Haghighi; Albrecht G Schmidt; Brian D Hoit; Angela G Brittsan; Atsuko Yatani; J William Lester; Jing Zhai; Y Kimura; Gerald W Dorn; David H MacLennan; Evangelia G Kranias
Superinhibition of sarcoplasmic reticulum function by phospholamban induces cardiac contractile failure.
The Journal of biological chemistry 2001;276(26):24145-52.
2001: Bruce Aronow; Tsuyoshi Toyokawa; AM Canning; K Haghighi; U Delling; Evangelia G Kranias; J D Molkentin; Gerald W Dorn
Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy.
Physiological genomics 2001;6(1):19-28.
2001: Jay Slack; Ingrid L Grupp; Rajesh Dash; D Holder; A Schmidt; Michael J Gerst; T Tamura; Carola Gabriella Tilgmann; Paul F James; R Johnson; A M Gerdes; Evangelia G Kranias
The enhanced contractility of the phospholamban-deficient mouse heart persists with aging.
Journal of molecular and cellular cardiology 2001;33(5):1031-40.
2001: Yoji Sato; Helen Kiriazis; Atsuko Yatani; Albrecht G Schmidt; Harvey Hahn; DG Ferguson; H Sako; S Mitarai; R Honda; L Mesnard-Rouiller; Konrad Frank; B Beyermann; Guangyu Wu; K Fujimori; Gerald W Dorn; Evangelia G Kranias
Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation.
The Journal of biological chemistry 2001;276(12):9392-9.
2001: T R Shannon; G Chu; Evangelia G Kranias; Donald M Bers
Phospholamban decreases the energetic efficiency of the sarcoplasmic reticulum Ca pump.
The Journal of biological chemistry 2001;276(10):7195-201.
2001: Rajesh Dash; Vivek J Kadambi; Albrecht G Schmidt; NM Tepe; Danuta Biniakiewicz; Michael J Gerst; AM Canning; William T Abraham; Brian D Hoit; Stephen B Liggett; John N Lorenz; Gerald W Dorn; Evangelia G Kranias
Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality.
Circulation 2001;103(6):889-96.
2000: Guoxiang Chu; J William Lester; Karen B Young; W Luo; Jing Zhai; Evangelia G Kranias
A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta -agonists.
The Journal of biological chemistry 2000;275(49):38938-43.
2000: Angela G Brittsan; Evangelia G Kranias
Phospholamban and cardiac contractile function.
Journal of molecular and cellular cardiology 2000;32(12):2131-9.
2000: Konrad Frank; Carola Gabriella Tilgmann; T R Shannon; Donald M Bers; Evangelia G Kranias
Regulatory role of phospholamban in the efficiency of cardiac sarcoplasmic reticulum Ca2+ transport.
Biochemistry 2000;39(46):14176-82.
2000: Albrecht G Schmidt; Vivek J Kadambi; NA Ball; Yoji Sato; Richard A Walsh; Evangelia G Kranias; Brian D Hoit
Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation and pulsus alternans in vivo.
Journal of molecular and cellular cardiology 2000;32(9):1735-44.
2000: Elena Zvaritch; Peter H Backx; F Jirik; Y Kimura; Stella de Leon; Albrecht G Schmidt; Brian D Hoit; J William Lester; Evangelia G Kranias; David H MacLennan
The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility.
The Journal of biological chemistry 2000;275(20):14985-91.
2000: Angela G Brittsan; Andrew N Carr; Albrecht G Schmidt; Evangelia G Kranias
Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban.
The Journal of biological chemistry 2000;275(16):12129-35.
2000: Jing Zhai; Albrecht G Schmidt; Brian D Hoit; Y Kimura; David H MacLennan; Evangelia G Kranias
Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.
The Journal of biological chemistry 2000;275(14):10538-44.
2000: Brian D Hoit; Vivek J Kadambi; D A Tramuta; NA Ball; Evangelia G Kranias; Richard A Walsh
Influence of sarcoplasmic reticulum calcium loading on mechanical and relaxation restitution.
American journal of physiology. Heart and circulatory physiology 2000;278(3):H958-63.
2000: L Li; Jaime DeSantiago; G Chu; Evangelia G Kranias; Donald M Bers
Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation.
American journal of physiology. Heart and circulatory physiology 2000;278(3):H769-79.
2000: Robert H G Schwinger; Klara Brixius; Persephone Savvidou-Zaroti; Birgit Bölck; Carsten Zobel; Konrad Frank; Evangelia G Kranias; S Hoischen; Erland Erdmann
The enhanced contractility in phospholamban deficient mouse hearts is not associated with alterations in (Ca2+)-sensitivity or myosin ATPase-activity of the contractile proteins.
Basic research in cardiology 2000;95(1):12-8.
2000: Evangelia G Kranias
Commentary on the special topic section on the use of transgenic models.
Annual review of physiology 2000;62():965-9.
2000: Helen Kiriazis; Evangelia G Kranias
Genetically engineered models with alterations in cardiac membrane calcium-handling proteins.
Annual review of physiology 2000;62():321-51.
1999: NM Tepe; John N Lorenz; Atsuko Yatani; Rajesh Dash; Evangelia G Kranias; Gerald W Dorn; Stephen B Liggett
Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling.
Biochemistry 1999;38(50):16706-13.
1999: Brian D Hoit; D A Tramuta; Vivek J Kadambi; Rajesh Dash; NA Ball; Evangelia G Kranias; Richard A Walsh
Influence of transgenic overexpression of phospholamban on postextrasystolic potentiation.
Journal of molecular and cellular cardiology 1999;31(11):2007-15.
1999: M Jane Lalli; S Shimizu; Roy L Sutliff; Evangelia G Kranias; Richard J Paul
[Ca2+]i homeostasis and cyclic nucleotide relaxation in aorta of phospholamban-deficient mice.
The American journal of physiology 1999;277(3 Pt 2):H963-70.
1999: Angela G Brittsan; E Kiss; István Ferenc Édes; Ingrid L Grupp; G Grupp; Evangelia G Kranias
The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
Journal of molecular and cellular cardiology 1999;31(9):1725-37.
1999: Atsuko Yatani; Konrad Frank; H Sako; Evangelia G Kranias; Gerald W Dorn
Cardiac-specific overexpression of Galphaq alters excitation-contraction coupling in isolated cardiac myocytes.
Journal of molecular and cellular cardiology 1999;31(7):1327-36.
1999: Vivek J Kadambi; NA Ball; Evangelia G Kranias; Richard A Walsh; Brian D Hoit
Modulation of force-frequency relation by phospholamban in genetically engineered mice.
The American journal of physiology 1999;276(6 Pt 2):H2245-50.
1999: Roy L Sutliff; James B Hoying; Vivek J Kadambi; Evangelia G Kranias; Richard J Paul
Phospholamban is present in endothelial cells and modulates endothelium-dependent relaxation. Evidence from phospholamban gene-ablated mice.
Circulation research 1999;84(3):360-4.
1998: Guoxiang Chu; L Li; Yoji Sato; Judy M Harrer; Vivek J Kadambi; Brian D Hoit; Donald M Bers; Evangelia G Kranias
Pentameric assembly of phospholamban facilitates inhibition of cardiac function in vivo.
The Journal of biological chemistry 1998;273(50):33674-80.
1998: Vivek J Kadambi; Evangelia G Kranias
Genetically engineered mice: model systems for left ventricular failure.
Journal of cardiac failure 1998;4(4):349-61.
1998: Yoji Sato; DG Ferguson; H Sako; Gerald W Dorn; Vivek J Kadambi; Atsuko Yatani; Brian D Hoit; Richard A Walsh; Evangelia G Kranias
Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice.
The Journal of biological chemistry 1998;273(43):28470-7.
1998: E Kiss; Angela G Brittsan; István Ferenc Édes; Ingrid L Grupp; G Grupp; Evangelia G Kranias
Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts.
Circulation research 1998;83(6):608-13.
1998: Guoxiang Chu; DG Ferguson; István Ferenc Édes; E Kiss; Yoji Sato; Evangelia G Kranias
Phospholamban ablation and compensatory responses in the mammalian heart.
Annals of the New York Academy of Sciences 1998;853():49-62.
1998: Vivek J Kadambi; KL Koss; Ingrid L Grupp; Evangelia G Kranias
Phospholamban modulates murine atrial contractile parameters and responses to beta-adrenergic agonists.
Journal of molecular and cellular cardiology 1998;30(7):1275-84.
1998: Y Takeishi; G Chu; D M Kirkpatrick; Z Li; Hisao Wakasaki; Evangelia G Kranias; George L King; Richard A Walsh
In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts.
The Journal of clinical investigation 1998;102(1):72-8.
1998: L Li; G Chu; Evangelia G Kranias; Donald M Bers
Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects.
The American journal of physiology 1998;274(4 Pt 2):H1335-47.
1998: W Luo; Guoxiang Chu; Yoji Sato; Z Zhou; Vivek J Kadambi; Evangelia G Kranias
Transgenic approaches to define the functional role of dual site phospholamban phosphorylation.
The Journal of biological chemistry 1998;273(8):4734-9.
1998: H Masaki; H Sako; Vivek J Kadambi; Yoji Sato; Evangelia G Kranias; Atsuko Yatani
Overexpression of phospholamban alters inactivation kinetics of L-type Ca2+ channel currents in mouse atrial myocytes.
Journal of molecular and cellular cardiology 1998;30(2):317-25.
1998: M Zhou; Roy L Sutliff; Richard J Paul; John N Lorenz; James B Hoying; Christian Haudenschild; M Yin; J D Coffin; L Kong; Evangelia G Kranias; W Luo; Gregory P Boivin; JJ Duffy; Sharon Pawlowski; Thomas Doetschman
Fibroblast growth factor 2 control of vascular tone.
Nature medicine 1998;4(2):201-7.
1997: Kobra Haghighi; Vivek J Kadambi; KL Koss; W Luo; Judy M Harrer; S Ponniah; Z Zhou; Evangelia G Kranias
In vitro and in vivo promoter analyses of the mouse phospholamban gene.
Gene 1997;203(2):199-207.
1997: John N Lorenz; Evangelia G Kranias
Regulatory effects of phospholamban on cardiac function in intact mice.
The American journal of physiology 1997;273(6 Pt 2):H2826-31.
1997: H Sako; Stuart A Green; Evangelia G Kranias; Atsuko Yatani
Modulation of cardiac Ca2+ channels by isoproterenol studied in transgenic mice with altered SR Ca2+ content.
The American journal of physiology 1997;273(5 Pt 1):C1666-72.
1997: Vivek J Kadambi; Evangelia G Kranias
Phospholamban: a protein coming of age.
Biochemical and biophysical research communications 1997;239(1):1-5.
1997: Guoxiang Chu; Gerald W Dorn; W Luo; Judy M Harrer; Vivek J Kadambi; Richard A Walsh; Evangelia G Kranias
Monomeric phospholamban overexpression in transgenic mouse hearts.
Circulation research 1997;81(4):485-92.
1997: Jay Slack; Ingrid L Grupp; DG Ferguson; N Rosenthal; Evangelia G Kranias
Ectopic expression of phospholamban in fast-twitch skeletal muscle alters sarcoplasmic reticulum Ca2+ transport and muscle relaxation.
The Journal of biological chemistry 1997;272(30):18862-8.
1997: Jay Slack; Ingrid L Grupp; W Luo; Evangelia G Kranias
Phospholamban ablation enhances relaxation in the murine soleus.
The American journal of physiology 1997;273(1 Pt 1):C1-6.
1997: J Lalli; Judy M Harrer; W Luo; Evangelia G Kranias; Richard J Paul
Targeted ablation of the phospholamban gene is associated with a marked decrease in sensitivity in aortic smooth muscle.
Circulation research 1997;80(4):506-13.
1997: E Kiss; István Ferenc Édes; Y Sato; W Luo; Stephen B Liggett; Evangelia G Kranias
beta-Adrenergic regulation of cAMP and protein phosphorylation in phospholamban-knockout mouse hearts.
The American journal of physiology 1997;272(2 Pt 2):H785-90.
1997: H Masaki; Y Sato; W Luo; Evangelia G Kranias; Atsuko Yatani
Phospholamban deficiency alters inactivation kinetics of L-type Ca2+ channels in mouse ventricular myocytes.
The American journal of physiology 1997;272(2 Pt 2):H606-12.
1997: KL Koss; Ingrid L Grupp; Evangelia G Kranias
The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility.
Basic research in cardiology 1997;92 Suppl 1():17-24.
1997: Judy M Harrer; Kobra Haghighi; H W Kim; DG Ferguson; Evangelia G Kranias
Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.
The American journal of physiology 1997;272(1 Pt 2):H57-66.
1996: Guoxiang Chu; W Luo; Jay Slack; Carola Gabriella Tilgmann; W E Sweet; Matthias Spindler; Kurt W Saupe; Gregory P Boivin; Christine S Moravec; Mohammed A Matlib; Ingrid L Grupp; Joanne S Ingwall; Evangelia G Kranias
Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts.
Circulation research 1996;79(6):1064-76.
1996: K L Koss; Evangelia G Kranias
Phospholamban: a prominent regulator of myocardial contractility.
Circulation research 1996;79(6):1059-63.
1996: Beata M Wolska; M O Stojanovic; W Luo; Evangelia G Kranias; R John Solaro
Effect of ablation of phospholamban on dynamics of cardiac myocyte contraction and intracellular Ca2+.
The American journal of physiology 1996;271(1 Pt 1):C391-7.
1996: W Luo; Beata M Wolska; Ingrid L Grupp; Judy M Harrer; Kobra Haghighi; DG Ferguson; Jay Slack; G Grupp; Thomas Doetschman; R John Solaro; Evangelia G Kranias
Phospholamban gene dosage effects in the mammalian heart.
Circulation research 1996;78(5):839-47.
1996: Vivek J Kadambi; S Ponniah; Judy M Harrer; Brian D Hoit; Gerald W Dorn; R A Walsh; Evangelia G Kranias
Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
The Journal of clinical investigation 1996;97(2):533-9.
1995: E Kiss; NA Ball; Evangelia G Kranias; R A Walsh
Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca(2+)-ATPase protein levels. Effects on Ca2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure.
Circulation research 1995;77(4):759-64.
1995: Grazyna Szymanska; Ingrid L Grupp; Jay Slack; Judy M Harrer; Evangelia G Kranias
Alterations in sarcoplasmic reticulum calcium uptake, relaxation parameters and their responses to beta-adrenergic agonists in the developing rabbit heart.
Journal of molecular and cellular cardiology 1995;27(9):1819-29.
1995: Brian D Hoit; S F Khoury; Evangelia G Kranias; NA Ball; R A Walsh
In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency.
Circulation research 1995;77(3):632-7.
1995: K L Koss; S Ponniah; W K Jones; Ingrid L Grupp; Evangelia G Kranias
Differential phospholamban gene expression in murine cardiac compartments. Molecular and physiological analyses.
Circulation research 1995;77(2):342-53.
1995: István Ferenc Édes; E Kiss; Y Kitada; F M Powers; Julius Gy Papp; Evangelia G Kranias; R John Solaro
Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
Circulation research 1995;77(1):107-13.
1995: Judy M Harrer; E Kiss; Evangelia G Kranias
Application of the immunoblot technique for quantitation of protein levels in cardiac homogenates.
BioTechniques 1995;18(6):995-8.
1995: Judy M Harrer; S Ponniah; DG Ferguson; Evangelia G Kranias
Expression of phospholamban in C2C12 cells and regulation of endogenous SERCA1 activity.
Molecular and cellular biochemistry 1995;146(1):13-21.
1994: Judy M Harrer; Evangelia G Kranias
Characterization of the molecular form of cardiac phospholamban.
Molecular and cellular biochemistry 1994;140(2):185-93.
1994: W Luo; Ingrid L Grupp; Judy M Harrer; S Ponniah; G Grupp; JJ Duffy; Thomas Doetschman; Evangelia G Kranias
Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
Circulation research 1994;75(3):401-9.
1994: E Kiss; G Jakab; Evangelia G Kranias; István Ferenc Édes
Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.
Circulation research 1994;75(2):245-51.
1994: G Jakab; E Kiss; Evangelia G Kranias; István Ferenc Édes
Effect of thyroid status on basal phosphorylation of cardiac myofibrillar phosphoproteins in rats.
Cardioscience 1994;5(1):19-24.
1993: G Jakab; E Kiss; Evangelia G Kranias; István Ferenc Édes
Effect of thyroid status on phosphatidylinositols in rat heart.
Cardioscience 1993;4(4):257-62.
1993: C D Hardin; C Zhang; Evangelia G Kranias; N A Steenaart; L Raeymaekers; Richard J Paul
Regulation of glycolytically fueled Ca2+ uptake in smooth muscle plasmalemmal vesicles by phosphorylation.
The American journal of physiology 1993;265(4 Pt 2):H1326-33.
1993: L Talosi; István Ferenc Édes; Evangelia G Kranias
Intracellular mechanisms mediating reversal of beta-adrenergic stimulation in intact beating hearts.
The American journal of physiology 1993;264(3 Pt 2):H791-7.
1992: J R Ganim; W Luo; S Ponniah; Ingrid L Grupp; H W Kim; DG Ferguson; Vivek J Kadambi; J C Neumann; Thomas Doetschman; Evangelia G Kranias
Mouse phospholamban gene expression during development in vivo and in vitro.
Circulation research 1992;71(5):1021-30.
1992: G Szymańska; H W Kim; John Cuppoletti; Evangelia G Kranias
Regulation of the skeletal sarcoplasmic reticulum Ca(2+)-ATPase by phospholamban and negatively charged phospholipids in reconstituted phospholipid vesicles.
Molecular and cellular biochemistry 1992;114(1-2):65-71.
1992: C Zhang; Richard J Paul; Evangelia G Kranias
Calmodulin stimulation of smooth muscle plasmalemmal vesicle Ca2+ uptake: direct or indirect effect?
The American journal of physiology 1992;263(2 Pt 2):H366-71.
1992: L Talosi; Evangelia G Kranias
Effect of alpha-adrenergic stimulation on activation of protein kinase C and phosphorylation of proteins in intact rabbit hearts.
Circulation research 1992;70(4):670-8.
1992: N A Steenaart; J R Ganim; J Di Salvo; Evangelia G Kranias
The phospholamban phosphatase associated with cardiac sarcoplasmic reticulum is a type 1 enzyme.
Archives of biochemistry and biophysics 1992;293(1):17-24.
1991: István Ferenc Édes; L Talosi; Evangelia G Kranias
The effect of alpha-adrenergic agents and protein kinase C activators on protein phosphorylation in isolated guinea pig hearts.
European heart journal 1991;12 Suppl F():143-4.
1991: István Ferenc Édes; L Talosi; Evangelia G Kranias
Effect of alpha adrenergic agents and phorbol esters on phosphorylation of sarcolemmal proteins in beating guinea pig hearts.
Cardiovascular research 1991;25(6):510-5.
1991: Ramesh Gupta; E F Young; DG Ferguson; Evangelia G Kranias
Regulation of rat cardiac nuclei-associated Mg(2+)-NTPase by phosphorylation.
Molecular and cellular biochemistry 1991;102(2):165-72.
1991: G Szymańska; H W Kim; Evangelia G Kranias
Reconstitution of the skeletal sarcoplasmic reticulum Ca2(+)-pump: influence of negatively charged phospholipids.
Biochimica et biophysica acta 1991;1091(2):127-34.
1990: B A Davis; István Ferenc Édes; Ramesh Gupta; E F Young; H W Kim; N A Steenaart; Grazyna Szymanska; Evangelia G Kranias
The role of phospholamban in the regulation of calcium transport by cardiac sarcoplasmic reticulum.
Molecular and cellular biochemistry 1990;99(2):83-8.
1990: István Ferenc Édes; Evangelia G Kranias
The effect of phorbol esters and diacylglycerol analogues on the basal phosphoinositide turnover in isolated guinea pig hearts.
Cardioscience 1990;1(4):265-74.
1990: István Ferenc Édes; Evangelia G Kranias
Phospholamban and troponin I are substrates for protein kinase C in vitro but not in intact beating guinea pig hearts.
Circulation research 1990;67(2):394-400.
1990: G Szymańska; H W Kim; John Cuppoletti; Evangelia G Kranias
Regulation of the skeletal sarcoplasmic reticulum Ca2+ pump by phospholamban in reconstituted phospholipid vesicles.
Membrane biochemistry 1990;9(3):191-202.
1990: H W Kim; N A Steenaart; DG Ferguson; Evangelia G Kranias
Functional reconstitution of the cardiac sarcoplasmic reticulum Ca2(+)-ATPase with phospholamban in phospholipid vesicles.
The Journal of biological chemistry 1990;265(3):1702-9.
1990: István Ferenc Édes; Evangelia G Kranias
Characterization of cytoplasmic and membrane-associated phosphatidylinositol 4,5-biphosphate phospholipase C activities in guinea pig ventricles.
Basic research in cardiology 1990;85(1):78-87.
1989: István Ferenc Édes; R John Solaro; Evangelia G Kranias
Changes in phosphoinositide turnover in isolated guinea pig hearts stimulated with isoproterenol.
Circulation research 1989;65(4):989-96.
1989: Ramesh Gupta; Evangelia G Kranias
Purification and characterization of a calcium-calmodulin-dependent phospholamban kinase from canine myocardium.
Biochemistry 1989;28(14):5909-16.
1989: E F Young; M J McKee; DG Ferguson; Evangelia G Kranias
Structural characterization of phospholamban in cardiac sarcoplasmic reticulum membranes by cross-linking.
Membrane biochemistry 1989;8(2):95-106.
1989: S T Rapundalo; R John Solaro; Evangelia G Kranias
Inotropic responses to isoproterenol and phosphodiesterase inhibitors in intact guinea pig hearts: comparison of cyclic AMP levels and phosphorylation of sarcoplasmic reticulum and myofibrillar proteins.
Circulation research 1989;64(1):104-11.
1988: Evangelia G Kranias; N A Steenaart; J Di Salvo
Purification and characterization of phospholamban phosphatase from cardiac muscle.
The Journal of biological chemistry 1988;263(30):15681-7.
1988: DG Ferguson; E F Young; L Raeymaekers; Evangelia G Kranias
Localization of phospholamban in smooth muscle using immunogold electron microscopy.
The Journal of cell biology 1988;107(2):555-62.
1988: Evangelia G Kranias; Ramesh Gupta; G Jakab; H W Kim; N A Steenaart; S T Rapundalo
The role of protein kinases and protein phosphatases in the regulation of cardiac sarcoplasmic reticulum function.
Molecular and cellular biochemistry 1988;82(1-2):37-44.
1988: G Jakab; Evangelia G Kranias
Phosphorylation and dephosphorylation of purified phospholamban and associated phosphatidylinositides.
Biochemistry 1988;27(10):3799-806.
1988: G Jakab; S T Rapundalo; R John Solaro; Evangelia G Kranias
Phosphorylation of phospholipids in isolated guinea pig hearts stimulated with isoprenaline.
The Biochemical journal 1988;251(1):189-94.
1988: J L Garvey; Evangelia G Kranias; R John Solaro
Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts.
The Biochemical journal 1988;249(3):709-14.
1987: H W Kim; D H Kim; N Ikemoto; Evangelia G Kranias
Lack of effects of calcium X calmodulin-dependent phosphorylation on Ca2+ release from cardiac sarcoplasmic reticulum.
Biochimica et biophysica acta 1987;903(2):333-40.
1987: Ramesh Gupta; B A Davis; Evangelia G Kranias
Mechanism of the stimulation of cardiac sarcoplasmic reticulum calcium pump by calmodulin.
Membrane biochemistry 1987;7(2):73-86.
1987: István Ferenc Édes; Evangelia G Kranias
Regulation of cardiac sarcoplasmic reticulum function by phospholamban.
Membrane biochemistry 1987;7(3):175-92.
1985: Evangelia G Kranias; J L Garvey; R D Srivastava; R John Solaro
Phosphorylation and functional modifications of sarcoplasmic reticulum and myofibrils in isolated rabbit hearts stimulated with isoprenaline.
The Biochemical journal 1985;226(1):113-21.